ID

23230

Beschreibung

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00198133

Link

https://clinicaltrials.gov/show/NCT00198133

Stichworte

Versionen (1)
  1. 29.06.17 29.06.17 -
Hochgeladen am

29. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Thymoma NCT00198133

Englisch

Eligibility Thymoma NCT00198133

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Thymoma NCT00198133
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed invasive, recurrent or metastatic thymoma or thymic carcinoma not amenable to potentially curative therapy by surgery. original biopsy of tumor is sufficient for diagnoses unless otherwise clinically indicated.
Beschreibung

Thymoma invasive | Thymoma recurrent | Thymoma metastatic | Thymic Carcinoma Curative Surgery Unsuccessful | Thymoma Biopsy

Datentyp

boolean

Alias
UMLS CUI [1]
C0278846
UMLS CUI [2]
C0278848
UMLS CUI [3,1]
C0040100
UMLS CUI [3,2]
C1522484
UMLS CUI [4,1]
C0205969
UMLS CUI [4,2]
C1511562
UMLS CUI [4,3]
C1272705
UMLS CUI [5,1]
C0040100
UMLS CUI [5,2]
C0005558
patients must have measurable disease with at least one bidimensional measurable lesion. any scans or x-rays used to document measurable disease must be obtained with 6 weeks prior to registration.
Beschreibung

Measurable lesion 2-Dimensional Quantity | Measurable Disease Scan | Measurable Disease X-ray

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0441633
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C0034571
patients may have had prior chemotherapy for metastatic disease
Beschreibung

Chemotherapy Neoplasm Metastasis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0027627
adequate organ function as defined by: bili </=1.5; calc. crt clr of >/=45; hematologic-granulocytes >/=1500 & plt >/=100k.
Beschreibung

Organ function | Serum total bilirubin measurement | Ratio Calcium Creatinine clearance | Hematology | Granulocyte count | Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C1278039
UMLS CUI [3,1]
C0456603
UMLS CUI [3,2]
C0006675
UMLS CUI [3,3]
C0812399
UMLS CUI [4]
C0200627
UMLS CUI [5]
C0857490
UMLS CUI [6]
C0032181
patients who are receiving a stable dose of corticosteroids for myasthenia gravis are eligible.
Beschreibung

Adrenal Cortex Hormones Dose Stable | Myasthenia Gravis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0026896
ecog performance status of 0 or 1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute intercurrent infection or complications
Beschreibung

Communicable Disease | Complication

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0009566
pregnancy or lactating patients
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
inability to interrupt aspirin or other nonsteroidal anti-inflammatory agents for a 5-day period (8-day period for long-acting agents.
Beschreibung

Aspirin Discontinue Unable | Non-Steroidal Anti-Inflammatory Agents Discontinue Unable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
presence of clinically relevant third-space fluid collections that cannot be controlled by a procedure
Beschreibung

Body Fluid Space Third Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005889
UMLS CUI [1,2]
C1883067
UMLS CUI [1,3]
C0205437
UMLS CUI [1,4]
C0205318
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Thymoma NCT00198133

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Thymoma NCT00198133
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Thymoma invasive | Thymoma recurrent | Thymoma metastatic | Thymic Carcinoma Curative Surgery Unsuccessful | Thymoma Biopsy
Item
histologically confirmed invasive, recurrent or metastatic thymoma or thymic carcinoma not amenable to potentially curative therapy by surgery. original biopsy of tumor is sufficient for diagnoses unless otherwise clinically indicated.
boolean
C0278846 (UMLS CUI [1])
C0278848 (UMLS CUI [2])
C0040100 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
C0205969 (UMLS CUI [4,1])
C1511562 (UMLS CUI [4,2])
C1272705 (UMLS CUI [4,3])
C0040100 (UMLS CUI [5,1])
C0005558 (UMLS CUI [5,2])
Measurable lesion 2-Dimensional Quantity | Measurable Disease Scan | Measurable Disease X-ray
Item
patients must have measurable disease with at least one bidimensional measurable lesion. any scans or x-rays used to document measurable disease must be obtained with 6 weeks prior to registration.
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0441633 (UMLS CUI [2,2])
C1513041 (UMLS CUI [3,1])
C0034571 (UMLS CUI [3,2])
Chemotherapy Neoplasm Metastasis
Item
patients may have had prior chemotherapy for metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Organ function | Serum total bilirubin measurement | Ratio Calcium Creatinine clearance | Hematology | Granulocyte count | Platelet Count measurement
Item
adequate organ function as defined by: bili </=1.5; calc. crt clr of >/=45; hematologic-granulocytes >/=1500 & plt >/=100k.
boolean
C0678852 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0456603 (UMLS CUI [3,1])
C0006675 (UMLS CUI [3,2])
C0812399 (UMLS CUI [3,3])
C0200627 (UMLS CUI [4])
C0857490 (UMLS CUI [5])
C0032181 (UMLS CUI [6])
Adrenal Cortex Hormones Dose Stable | Myasthenia Gravis
Item
patients who are receiving a stable dose of corticosteroids for myasthenia gravis are eligible.
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0026896 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Communicable Disease | Complication
Item
acute intercurrent infection or complications
boolean
C0009450 (UMLS CUI [1])
C0009566 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or lactating patients
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Aspirin Discontinue Unable | Non-Steroidal Anti-Inflammatory Agents Discontinue Unable
Item
inability to interrupt aspirin or other nonsteroidal anti-inflammatory agents for a 5-day period (8-day period for long-acting agents.
boolean
C0004057 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Body Fluid Space Third Uncontrolled
Item
presence of clinically relevant third-space fluid collections that cannot be controlled by a procedure
boolean
C0005889 (UMLS CUI [1,1])
C1883067 (UMLS CUI [1,2])
C0205437 (UMLS CUI [1,3])
C0205318 (UMLS CUI [1,4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video